Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: An analysis of Medicare claims data
Annals of Rheumatic Diseases Oct 03, 2017
Singh JA, et al. - The comparative efficacy of allopurinol versus febuxostat for preventing incident renal disease in elderly was evaluated in this study. It was concluded that the allopurinol was related to a lower risk of incident renal disease in elderly patients than febuxostat. Future studies need to analyze the mechanism of this potential renal benefit of allopurinol.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries